Showing results (21-30 of 113) with videos related to
Sort By:
Pageof 12
Trends in Molecular Medicine|June 4, 2019
Abandoning the Notion of Non-Small Cell Lung CancerValeria Relli, Marco Trerotola, Emanuela Guerra, et al.Oncotarget|November 27, 2018
Distinct lung cancer subtypes associate to distinct drivers of tumor progressionValeria Relli, Marco Trerotola, Emanuela Guerra, et al.Journal of Cellular Physiology|March 2, 2012
Trop-2 inhibits prostate cancer cell adhesion to fibronectin through the β1 integrin-RACK1 axisMarco Trerotola, Jing Li, Saverio Alberti, et al.FEBS Letters|August 7, 2002
Oligomerization of DsRed is required for the generation of a functional red fluorescent chromophoreAndrea Sacchetti, Vinod Subramaniam, Thomas M Jovin, et al.Frontiers in Oncology|July 17, 2023
A non-mutated TROP2 fingerprint in cancer geneticsEmanuela Guerra, Roberta Di Pietro, Gianmarco Stati, et al.International Journal of Cancer|September 5, 2002
Presentation of native TROP-2 tumor antigens to human cytotoxic T lymphocytes by engineered antigen-presenting cellsGiorgio Mangino, Maria Grazia Capri, Vincenzo Barnaba, et al.International Journal of Molecular Sciences|January 11, 2022
Cancer-Homing CAR-T Cells and Endogenous Immune Population DynamicsEmanuela Guerra, Roberta Di Pietro, Mariangela Basile, et al.Molecular Cancer Therapeutics|March 15, 2023
3D-Informed Targeting of the Trop-2 Signal-Activation Site Drives Selective Cancer VulnerabilityEmanuela Guerra, Marco Trerotola, Valeria Relli, et al.Oncogene|February 8, 2022
Trop-2, Na+/K+ ATPase, CD9, PKCα, cofilin assemble a membrane signaling super-complex that drives colorectal cancer growth and invasionEmanuela Guerra, Valeria Relli, Martina Ceci, et al.Biochimica Et Biophysica Acta|December 14, 2004
Meta-analysis of the role of p53 status in isogenic systems tested for sensitivity to cytotoxic antineoplastic drugsGuido Cimoli, Davide Malacarne, Raffaella Ponassi, et al.Pageof 12